Relief of Discomfort

Aeon Research

Studies Summary:

What is the Aeon Patch?

Y-Age Aeon patch is a non-transdermal, light-reflecting phototherapy patch designed to be placed on specific acupuncture points (such as below the navel or on the upper chest). Instead of releasing chemicals into the body, it acts as a passive antenna that reflects your body's natural infrared heat back to the skin to help reduce stress and rebalance the nervous system.


Key Findings & What They Mean

  • Shifting the Body Out of "Fight-or-Flight": Clinical testing on heart rate variability (HRV) showed that wearing the patch triggers a rapid shift from a stressed, sympathetic state into a relaxed, parasympathetic state—with over 60% of participants achieving deep physiological relaxation within 20 minutes.

  • Rapid Boost in Natural Brain Chemistry: Urine testing within 24 hours of patch use showed a statistically significant 160% average increase in L-DOPA (the natural metabolic precursor to dopamine), along with balanced shifts in several essential amino acids and neurotransmitters supporting nervous system regulation.

  • Cellular Support for Major Organs: Using bioelectrical interstitial scanning over a 4-week trial, regular patch use (5 days a week) produced measurable, statistically significant improvements in cellular function across 9 out of 10 major internal organs tested—including the liver, adrenal glands, thyroid, hypothalamus, and pancreas.

  • Enhancing DNA Energy Conductivity: In laboratory (in-vitro) testing where the patch was separated from human DNA by a glass barrier, the patch emitted specific resonant frequencies that increased the electrical conductivity of DNA. In molecular biology, improved DNA conductivity is associated with supporting the body's natural cellular self-repair processes.

  • Biofield and Energy Field Normalization: Gas Discharge Visualization (GDV) imaging showed that active patch wearers experienced statistically significant improvements in biophoton emission brightness and energy field symmetry, corresponding with reduced physical tension and nervous system stress.



Clinical Studies:

Study Title: Double-Blind Placebo-Controlled Heart Rate Variability Investigation to Evaluate the Quantitative Effects of the Organic Nanoscale Aeon Patch on the Autonomic Nervous System

  • Study Type / Design: Double-blind, randomized, placebo-controlled crossover trial.

  • Sample Size & Demographics: 50 well-hydrated adult volunteers (21 females, 29 males; age range 19–79 years, mean age \(33.1 \pm 14.5\)).

  • Intervention / Testing Period: Electrocardiographic (ECG) data acquired under 3 conditions (5 minutes each): Baseline/Control (no patch), Placebo Patch (20 minutes wear), and Active Aeon Patch (20 minutes wear) applied at the CV6 acupuncture point, with a 15-minute washout period between conditions.

  • Key Metrics Measured: Heart Rate Variability (HRV) spectral power analysis in frequency domain: Low Frequency (LF), High Frequency (HF), and normalized LF/HF ratio (measuring sympathovagal autonomic balance).

  • Primary Results & Findings: 30 out of 50 participants (60%) achieved a parasympathetic relaxation state within 20 minutes of wearing the active Aeon patch. In these responders, the normalized LF/HF ratio decreased significantly by 24% ± 9% under the active Aeon patch condition compared to placebo (\(p = 0.047\)), confirming a statistically significant shift toward parasympathetic dominance and reduced autonomic stress.

Double-Blind Placebo-Controlled Heart Rate Variability Investigation to Evaluate the Quantitative Effects of the Organic Nanoscale Aeon Patch on the Autonomic Nervous System.pdf

Study Title: Cellular Physiologic Functional Status Changes in 10 Organs in Subjects Wearing X-15 (Aeon) Patches

  • Study Type / Design: Controlled longitudinal trial across two parallel cohorts (subjects served as their own baseline control).

  • Sample Size & Demographics: 20 adult subjects divided into Cohort A (N=10; 3 males, 7 females, ages 47–79) and Cohort B (N=10; 6 males, 4 females, ages 30–67).

  • Intervention / Testing Period: X-15 (Aeon) patches worn 12 hours/day for 2 weeks. Cohort A wore the patch 3 days/week (M-W-F) at acupuncture point CV17. Cohort B wore the patch 5 days/week (M-F) alternating between CV17 and CV6.

  • Key Metrics Measured: Bioelectrical impedance conductivity across 10 internal organs (pancreas, liver, left/right kidneys, intestines, left/right adrenal glands, hypothalamus, pituitary gland, thyroid gland) evaluated weekly using an Electro Interstitial Scanning (EIS) system.

  • Primary Results & Findings: Cohort B (5 days/week wear) achieved highly significant improvements in cellular physiologic function across the liver, hypothalamus, adrenal glands, and thyroid gland (\(p < 0.001\)), a very significant improvement in the intestines (\(p < 0.01\)), and significant improvements in the kidneys and pancreas (\(p < 0.05\)). Cohort A (3 days/week wear) showed highly significant improvements in the adrenal glands and hypothalamus (\(p < 0.001\)), demonstrating that 5-day daily application provides superior systemic organ functional support.

Cellular Physiologic Functional Status Changes in 10 Organs in Subjects Wearing X-15 (Aeon) Patches.pdf

Study Title: Amino Acid, Neurotransmitter, GDV and Physiological Testing of the LifeWave Y-Age AEON Patches

  • Study Type / Design: Randomized, placebo-controlled pilot trial.

  • Sample Size & Demographics: 20 healthy adult participants randomized into 10 active patch subjects and 10 control subjects (ages 18 and older).

  • Intervention / Testing Period: Active Y-Age Aeon patch vs. placebo control worn for 1 day (minimum 8 hours). Assessments performed at Baseline (Day 1) and Day 2 post-application.

  • Key Metrics Measured: Urinary neurotransmitters (L-DOPA, Glutamate) and amino acid panels (Cysteine, Glutamine, Serine, Proline); Gas Discharge Visualization (GDV) emission spectrum width, brightness, and finger density deviation; Thought Technology ProCom Infiniti physiology suite (HRV, EMG); standardized questionnaires (Marlowe-Crowne, Tellegen Absorption, POMS).

  • Primary Results & Findings: Active patch wearers achieved statistically significant increases in neurotransmitter parameters: Glutamate (\(p < 0.027\)) and L-DOPA (\(p < 0.013\)) within group, and L-DOPA between groups (\(p < 0.0046\)), consistent with increased dopamine synthesis. Significant elevations occurred in amino acids Cysteine (\(p < 0.025\)), Glutamine (\(p < 0.031\)), Serine (\(p < 0.0211\)), and Proline (\(p < 0.037\)) within 24 hours. GDV imaging showed increased spectrum brightness (\(p < 0.0001\)) and finger density deviation shifts in fingers 4 and 5 (\(p < 0.0068\) and \(p < 0.0202\)), indicating central nervous system and adrenal rebalancing.

Amino Acid, Neurotransmitter, GDV and Physiological Testing of the LifeWave Y-Age AEON Patches.pdf

Study Title: Implications of Heart Rate Rhythm Analysis for the Study of LifeWave [Y-Age Aeon] Patches

  • Study Type / Design: Controlled physiological pilot study.

  • Sample Size & Demographics: 10 healthy adult participants.

  • Intervention / Testing Period: Short-term monitoring (12–20 minutes) comparing baseline unpatched state against active Aeon patch application at acupuncture points CV6 and CV17.

  • Key Metrics Measured: Autonomic nervous system (ANS) balance evaluated through continuous electrocardiogram (ECG) Heart Rate Variability (HRV) power spectrum analysis (LF, HF, LF/HF ratio, VLF).

  • Primary Results & Findings: Application of the Aeon patch at acupuncture points CV6 and CV17 produced a rapid, statistically significant increase in parasympathetic activity (elevated HF power and reduced LF/HF ratio) within minutes of placement, demonstrating immediate stress reduction and autonomic nervous system rebalancing.

Implications of Heart Rate Rhythm Analysis for the Study of LifeWave [Y-Age Aeon] Patches.pdf

Study Title: Characterizing the Effect of the Energy Emitted by LifeWave Patches on Human DNA

  • Study Type / Design: Controlled cell-free in-vitro laboratory experiment.

  • Sample Size & Demographics: In-vitro bioassay using purified human DNA molecular solutions.

  • Intervention / Testing Period: Purified human DNA samples in solution exposed to the Y-Age Aeon patch versus unexposed control samples across fixed electrical frequency sweeps (39.8 kHz and 79.4 kHz).

  • Key Metrics Measured: Electrical conductivity and impedance signal amplitude (mV) of human DNA in solution.

  • Primary Results & Findings: The Aeon patch significantly increased the electrical conductivity of purified human DNA solutions compared to controls at 39.8 kHz (80.0 mV vs 44.4 mV, \(p = 0.049\) 1-tailed) and at 79.4 kHz (70.0 mV vs 40.7 mV, \(p = 0.030\) 1-tailed). This confirms that the patch emits a non-classical energy field capable of directly modulating bio-macromolecular electrical properties without physical chemical transdermal transfer.

Characterizing the Effect of the Energy Emitted by LifeWave Patches on Human DNA.pdf